Tinde Sparebank (OSL:TINDE)
Norway · Delayed Price · Currency is NOK 129.00
+1.50 (1.18%)
At close: Jul 29, 2025
Verve Therapeutics Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Interest Income on Loans | 413.09 | 403.71 | 318.39 | 208.25 | 151.85 | 169.22 | Upgrade |
Interest Income on Investments | 48.3 | 48.11 | 40.51 | 28.35 | 16.06 | 15.47 | Upgrade |
Total Interest Income | 461.39 | 451.82 | 358.9 | 236.6 | 167.91 | 184.68 | Upgrade |
Interest Paid on Deposits | 261.47 | 253.76 | 175.28 | 80.66 | 46.91 | 68.73 | Upgrade |
Total Interest Expense | 261.47 | 253.76 | 175.28 | 80.66 | 46.91 | 68.73 | Upgrade |
Net Interest Income | 199.91 | 198.07 | 183.62 | 155.94 | 121 | 115.96 | Upgrade |
Net Interest Income Growth (YoY) | 5.46% | 7.87% | 17.75% | 28.88% | 4.35% | 4.29% | Upgrade |
Gain (Loss) on Sale of Investments | 2.58 | -1.38 | 4.13 | -2.5 | 1.67 | - | Upgrade |
Gain (Loss) on Sale of Equity Investments | -0.24 | -0.24 | - | - | - | - | Upgrade |
Other Non-Interest Income | 46.21 | 44.1 | 35.05 | 34.56 | 41.57 | 34.75 | Upgrade |
Total Non-Interest Income | 48.55 | 42.48 | 39.19 | 32.05 | 43.25 | 34.75 | Upgrade |
Non-Interest Income Growth (YoY) | 29.20% | 8.41% | 22.25% | -25.88% | 24.45% | 8.86% | Upgrade |
Revenues Before Loan Losses | 248.47 | 240.55 | 222.81 | 188 | 164.25 | 150.71 | Upgrade |
Provision for Loan Losses | 22.08 | 21.66 | 27.06 | 10.75 | 4.11 | 13.36 | Upgrade |
| 226.38 | 218.89 | 195.75 | 177.25 | 160.14 | 137.34 | Upgrade | |
Revenue Growth (YoY) | 15.32% | 11.82% | 10.43% | 10.69% | 16.60% | 0.01% | Upgrade |
Salaries and Employee Benefits | 69.6 | 65.15 | 57.03 | 47.13 | 44.67 | 45.13 | Upgrade |
Occupancy Expenses | 5.09 | 5.17 | 5.05 | 4.47 | 4.38 | 5.96 | Upgrade |
Selling, General & Administrative | 5.84 | 5.84 | 5.2 | 4.54 | 3.92 | - | Upgrade |
Other Non-Interest Expense | 45.53 | 42.74 | 44.84 | 46.13 | 39.68 | 47.98 | Upgrade |
Total Non-Interest Expense | 126.06 | 118.9 | 112.11 | 102.28 | 92.65 | 99.07 | Upgrade |
EBT Excluding Unusual Items | 100.32 | 99.98 | 83.63 | 74.97 | 67.48 | 38.28 | Upgrade |
Asset Writedown | - | - | - | - | - | -1.92 | Upgrade |
Pretax Income | 100.32 | 99.98 | 83.63 | 74.97 | 67.48 | 36.36 | Upgrade |
Income Tax Expense | 20.32 | 20.15 | 15.48 | 14.45 | 14.5 | 6.24 | Upgrade |
Net Income | 80 | 79.84 | 68.15 | 60.52 | 52.98 | 30.12 | Upgrade |
Preferred Dividends & Other Adjustments | 53.4 | 54.21 | 50.07 | 43.16 | 36.99 | 21.13 | Upgrade |
Net Income to Common | 26.6 | 25.62 | 18.08 | 17.36 | 15.99 | 9 | Upgrade |
Net Income Growth | 14.88% | 17.15% | 12.60% | 14.23% | 75.89% | -25.54% | Upgrade |
Basic Shares Outstanding | 3 | 3 | 2 | 2 | 2 | 2 | Upgrade |
Diluted Shares Outstanding | 3 | 3 | 2 | 2 | 2 | 2 | Upgrade |
Shares Change (YoY) | 41.86% | 27.89% | - | - | 10.58% | 56.16% | Upgrade |
EPS (Basic) | 9.54 | 10.20 | 9.20 | 8.83 | 8.14 | 5.06 | Upgrade |
EPS (Diluted) | 9.54 | 10.20 | 9.20 | 8.83 | 8.14 | 5.06 | Upgrade |
EPS Growth | 2.48% | 10.80% | 4.16% | 8.55% | 60.76% | -38.86% | Upgrade |
Dividend Per Share | 9.000 | 9.000 | 7.630 | 8.650 | 8.000 | 3.360 | Upgrade |
Dividend Growth | 17.95% | 17.95% | -11.79% | 8.13% | 138.09% | -59.42% | Upgrade |
Effective Tax Rate | 20.25% | 20.15% | 18.51% | 19.28% | 21.49% | 17.16% | Upgrade |
Source: S&P Global Market Intelligence. Banks template. Financial Sources.